By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

OK

By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

Novo Nordisk

In the last 8 hours

Ahead of Senate Hearing, Doctors Decry 'Exorbitant' Cost of Ozempic and Wegovy Common Dreams23:12 16-Sept-24

Yesterday

Novo Nordisk's latest RNA deal involves $530M biobucks to sing in Korro's opera FierceBiotech14:49 16-Sept-24

In the last 7 days

Should You Invest in This Under-the-Radar Weight Loss Stock? The Motley Fool11:14 15-Sept-24

2 Unstoppable Healthcare Stocks to Buy Right Now for Less Than $200 The Motley Fool10:37 14-Sept-24

Early Data for GLP-1 Pill; FAERS Tirzepatide Reports; AI Diabetes Voice Screening Medpage Today06:35 14-Sept-24

Liraglutide Helps Shed Weight in Young Children With Obesity TCTMD21:15 13-Sept-24

Novo Nordisk Sued Over 401(k) Funds, Handling of Forfeitures Bloomberg Law20:31 13-Sept-24

European Stocks Gain With Index Set for Best Week in a Month Mint19:20 13-Sept-24

European Stocks Gain as Index Notches Best Week in a Month BNN Bloomberg18:39 13-Sept-24

Dark side of Ozempic laid bare as Lottie Moss rushes to hospital after overdose The Mirror18:36 13-Sept-24

Novo Nordisk seeks to repurpose GLP-1s, again, for the brain BioWorld17:56 13-Sept-24

Cork at forefront of pharma's latest blockbuster drug Irish Examiner17:02 13-Sept-24

Pharma Stock Roundup: FDA Approves J&J's Tremfya for Ulcerative Colitis & More Zacks14:01 13-Sept-24

Novo Loses Mantle as Denmark’s Second-Biggest Company to DSV BNN Bloomberg13:05 13-Sept-24

New weight loss pill outperforms Wegovy in early trials Society for Endocrinology10:05 13-Sept-24

How Much Does It Really Cost To Produce Insulin? (Spanish) Pulitzer Center22:47 12-Sept-24

¿Cuánto cuesta realmente producir insulina? Pulitzer Center22:47 12-Sept-24

CDC data highlights surge in obesity rates, driving demand for weight loss drugs Invezz21:09 12-Sept-24

‘Dual-action’ weight-loss pill helps people drop 13% of body weight in three months in early… Fox News19:51 12-Sept-24

NVO Oral Obesity Pill Tops Wegovy; LLY, VKTX, GPCR Stocks Rise Zacks19:31 12-Sept-24

Novo Nordisk Stock Rises as Oral Obesity Pill Outshines Wegovy Zacks17:08 12-Sept-24

Forget Eli Lilly and Novo Nordisk: This Could Be the Best Weight Loss Stock to Buy Right Now The Motley Fool11:05 12-Sept-24

Novo's new weight-loss pill Amycretin beats Wegovy in trial Yahoo! US10:33 12-Sept-24

RNA-Based Therapeutics Market to Grow by USD 1.27 Billion (2024-2028) Due to Increased… PR Newswire (Press Release)23:13 11-Sept-24

The Insulin Oligopoly and the Diabetes Epidemic in Latin America Pulitzer Center21:11 11-Sept-24

GLP-1 hybrid drug being tested as weight-loss aid UPI20:40 11-Sept-24

13% weight loss in 3 months! Obesity pill amycretin shows promise of replacing Ozempic injections Study Finds20:24 11-Sept-24

Weight-loss pill from Wegovy makers cut body weight by up to 13% in early trial TurnTo23.com, California20:23 11-Sept-24

Novo Nordisk's longstanding GLP-1 reduced BMI by 7% in children in Phase 3 trial ENDPOINTS20:03 11-Sept-24

2 Weight Loss Drug Stocks Worth Stashing Away for Years 24/7 Wall St.19:49 11-Sept-24

Ozempic maker Novo Nordisk has an experimental anti-obesity pill with noteworthy early trial results Quartz18:35 11-Sept-24

The High Price of Insulin Makes Diabetes Management Difficult in Latin America Pulitzer Center17:19 11-Sept-24

El dinero o la salud: El alto precio de la insulina dificulta el control de la diabetes en América Latina Pulitzer Center16:39 11-Sept-24

Money or Health: The High Price of Insulin Makes Diabetes Management Difficult in Latin America (Spanish) Pulitzer Center16:39 11-Sept-24

Novo Nordisk hails ‘remarkable’ weight loss result for dual-acting oral drug in early trial FierceBiotech16:10 11-Sept-24

Ozempic maker has developed a pill that can cause weight loss of up to 13% in three months Fortune15:55 11-Sept-24

Novo Nordisk's experimental weight loss pill showed significant results in its first trial Quartz15:42 11-Sept-24

EASD 2024: Novo Nordisk’s Saxenda shows weight loss in children Pharmaceutical Technology14:49 11-Sept-24

Ozempic Maker Novo Nordisk Touts Encouraging Data From New Obesity Pill Showing Double Weight Loss Compared To Wegovy Benzinga14:26 11-Sept-24

Novo Nordisk’s New Obesity Pill Beats Wegovy In Early Trial Forbes13:20 11-Sept-24

Novo Nordisk's oral amycretin could lead to more weight loss beyond 12 weeks according to early-stage trial ENDPOINTS12:14 11-Sept-24

Novo Nordisk experimental obesity pill has mild-to-moderate side effects in early trial DD News12:11 11-Sept-24

Study backs role of Novo Nordisk obesity drug in children pharmaphorum11:48 11-Sept-24

Daily Pill Helps People Lose Weight, Combines GLP-1 With Other Drug HealthDay11:02 11-Sept-24

Novo Nordisk Reports Positive Results Of Weight-Loss Drug Liraglutide For Children As Young As 6, Eyes FDA And EMA… Benzinga09:21 11-Sept-24

The next big market for weight-loss drugs: children Business Insider07:25 11-Sept-24

Once-a-day oral weight loss drug shows promising results in reducing body weight News-Medical.Net03:39 11-Sept-24

Novo’s Saxenda Helped Kids as Young as Six Lose Weight in Trial BNN Bloomberg01:34 11-Sept-24

Novo Nordisk weight-loss drug is effective for kids as young as 6, study shows NECN, New England23:39 10-Sept-24

Weight-loss drug Saxenda effective for kids as young as 6, study shows ABC News23:12 10-Sept-24

Weight-loss market to see 16 new drugs by 2029, report estimates Yahoo! UK & Ireland19:48 10-Sept-24

Eli Lilly's weekly insulin is running into the same issue Novo Nordisk's did Quartz18:39 10-Sept-24

Eli Lilly, Novo Nordisk and other Big Pharmas back OAC’s ‘Your Weight Matters’ campaign… FiercePharma17:30 10-Sept-24

Growth Hormone Deficiency Market Size to Hit USD 8.5 Billion by 2032 | SNS Insider GlobeNewswire (Press Release)14:02 10-Sept-24

Kallyope Announces License Agreement with Novo Nordisk Business Wire (Press Release)13:09 10-Sept-24

Novo Nordisk: Low Dividend Yield, Decelerated Growth Rates, Hold For Now Seeking Alpha10:50 10-Sept-24

Novo Nordisk's blockbuster weight loss drug Wegovy to land in Korea in mid-October Korea Biomedical Review06:02 10-Sept-24

Weight-Loss Drug Linked to Fewer COVID Deaths The Good Men Project00:34 10-Sept-24

In the last month

Novo Nordisk Sues Over Ads For Diabetes, Weight Loss Drugs Law36021:55 9-Sept-24

Zealand to Broaden Trial of Weight-Loss Drug After Early Success BNN Bloomberg18:13 9-Sept-24

Novo Nordisk Launches Major Share Buyback TipRanks16:29 9-Sept-24

Novo Nordisk Advances Share Buyback Program TipRanks16:29 9-Sept-24

Novo Nordisk A/S - share repurchase programme GlobeNewswire (Press Release)15:12 9-Sept-24

Children's Growth Awareness Week: Why Growth Awareness Matters PR Newswire (Press Release)13:54 9-Sept-24

ArcanaBio Secures Funding from BioInnovation Institute to Revolutionize Healthcare with new… Business Wire (Press Release)07:19 9-Sept-24

Norway's Sovereign Investment Fund - an economic and financial success Bursa.ro22:05 8-Sept-24

Ozempic maker sued over claims drug led to woman’s colon removal The Independent17:18 6-Sept-24

Warren Buffett Detailed Fundamental Analysis - NVO Nasdaq17:12 6-Sept-24

Novo Nordisk not yet ready to bring in popular obesity, diabetes injectables The Times of India08:57 6-Sept-24

Global Short-Acting Insulin Market is Expected to Cross ~USD 9 Billion by 2030 | DelveInsight PR Newswire (Press Release)22:47 5-Sept-24

Behind the Headlines: Weight Loss Drugs; Price Controls; and Free COVID Therapies PharmTech.com20:20 5-Sept-24

Woman Sues Ozempic Manufacturer After Alleging Medication Led to Colon Removal: 'It Could Happen to You' People19:51 5-Sept-24

Woman Files Lawsuit Against Novo Nordisk Over Alleged Side Effects of Ozempic and Wegovy What's Trending18:38 5-Sept-24

Fake Ozempic Targets Weight-Loss Market: Forged Batches An International Concern Benzinga18:26 5-Sept-24

Eli Lilly Just Made Zepbound Even More Appealing. Here's What Smart Investors Need to Know. The Motley Fool13:24 5-Sept-24

‘No link between diabetes drugs and suicidal thoughts’ EasternEye12:06 5-Sept-24

Factbox-How to find and check an Ozempic batch number Yahoo! UK & Ireland10:13 5-Sept-24

Six biotech companies that could revolutionize obesity treatments Labiotech09:16 5-Sept-24

Novo Nordisk Korea to launch smart insulin pen cap Korea Biomedical Review05:35 5-Sept-24

Weight loss drugs allegedly landed this woman in the hospital. She's suing. CBS News18:05 4-Sept-24

No Evidence Linking Weight-Loss Drugs to Suicide, UK Probe Finds BNN Bloomberg17:24 4-Sept-24

A new weight loss drug from an Eli Lily partner targets the elderly Quartz15:26 4-Sept-24

Ozempic shortages will hit some EU countries only, says Novo Nordisk | REUTERS Reuters - YouTube14:12 4-Sept-24

Ozempic shortages in EU will not affect all member states - Novo Nordisk Yahoo! UK & Ireland08:25 4-Sept-24

Has Eli Lilly Destroyed Hims & Hers Upside? 24/7 Wall St.22:47 3-Sept-24

Novo Nordisk continues to grapple with patchy GLP-1 drug supply in Europe ENDPOINTS16:44 3-Sept-24

In Europe, shortages of Novo Nordisk's Ozempic to persist into Q4: letter FiercePharma16:18 3-Sept-24

The Ozempic shortage is getting worse Quartz16:01 3-Sept-24

Digital Marketing Trends in Type 2 Diabetes GlobeNewswire (Press Release)15:54 3-Sept-24

The Best Biotech Stock to Invest $1,000 in Right Now The Motley Fool14:53 3-Sept-24

Health Ministry in UAE to create national scientific guide for tackling obesity and weight management BioSpectrum Asia12:36 3-Sept-24

UAE MoHAP and Novo Nordisk partner for obesity management Pharmaceutical Technology11:19 3-Sept-24

Half of Denmark’s GDP growth in 2024 will be thanks to Novo Nordisk, analysts predict Fortune10:15 3-Sept-24

Novo to Supply Half of Danish Growth in 2024, Danske Says BNN Bloomberg05:47 3-Sept-24

New Study Finds Wegovy Reduces Covid Death Risk By 33 Percent Futurism17:17 31-Aug-24

3 No-Brainer Stocks to Buy in September The Motley Fool12:31 31-Aug-24

These 3 Factors Could Make Eli Lilly Stock a Better Buy Than Novo Nordisk Right Now The Motley Fool12:11 31-Aug-24

Semaglutide cuts death rates from cardiovascular disease and COVID-19 News-Medical.Net04:11 31-Aug-24

ESC 2024: Latest FLOW trial analysis highlights how Ozempic can benefit CKD patients Pharmaceutical Technology20:44 30-Aug-24

Novo Nordisk reveals post-hoc cardiovascular data for semaglutide ENDPOINTS19:18 30-Aug-24

Judge's Early Ruling May Shape Outcome In Ozempic, Wegovy Lawsuits Benzinga18:45 30-Aug-24

Novo Nordisk Executives Buy Company Shares TipRanks16:00 30-Aug-24

Novo Nordisk Touts Encouraging Wegovy Data To Lower Risk Of Severe Complications In Heart Failure Patients Benzinga15:01 30-Aug-24

Eli Lilly ramps up its fight against imitation weight-loss drugs Yahoo! US13:00 30-Aug-24

Wegovy reduced Covid deaths in obese patients, study finds Fortune11:33 30-Aug-24

This New Finding About Ozempic and Wegovy Could Hurt Novo Nordisk's Stock The Motley Fool11:25 30-Aug-24

Wegovy Reduced Covid Deaths in Obese Patients, Study Shows BNN Bloomberg10:08 30-Aug-24

Eli Lilly cutting cost of certain weight loss drugs by at least 50% FOX13 Seattle19:34 29-Aug-24

Catalent beats revenue estimates ahead of deal close with Novo Nordisk parent Yahoo! UK & Ireland13:12 29-Aug-24

I think one of this year’s stock market favourites is due a breather. Here’s why Motley Fool (UK)10:30 29-Aug-24

Five Funds to Exploit European Equities' Low Valuations Morningstar09:49 29-Aug-24

Why ‘Skinny Jabs’ Will Deepen America’s Health Crisis Organic Consumers Association05:07 29-Aug-24

Eli Lilly Launches Cheaper Single-Use Vials of Weight-Loss Drug Zepbound Investopedia18:08 28-Aug-24

Denmark’s Top Pension Fund Buys Weight-Loss Stocks After Run-Up BNN Bloomberg16:54 28-Aug-24

The GLP-1 Products and Players - Stocks to Watch Investorideas.com15:35 28-Aug-24

view more headlines

16 Sept 23:12

About our Novo Nordisk news

Latest news on Novo Nordisk, a global healthcare company focused on diabetes care, obesity treatment, and other serious chronic diseases. Get updates on Novo Nordisk's products, research, financial performance, and stock price.

Novo Nordisk is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark. Founded in 1923, the company has grown to become a global leader in diabetes care, with a strong presence in the fields of hemophilia, growth hormone therapy, and obesity treatment. Novo Nordisk's key products include insulin analogs like Tresiba and Levemir, GLP-1 receptor agonists such as Victoza and Ozempic, and obesity drugs like Saxenda and Wegovy.

Stay informed about the latest developments in Novo Nordisk's research and development pipeline, including updates on clinical trials, regulatory approvals, and new product launches. Our feed covers the company's ongoing efforts to innovate and improve treatments for diabetes, obesity, and other metabolic disorders, such as the development of oral semaglutide and the exploration of novel drug targets.

In addition to product news, our Novo Nordisk feed keeps you updated on the company's financial performance, including quarterly earnings reports, sales figures, and market share data. We also cover key events and announcements that may impact Novo Nordisk's stock price (NYSE: NVO), such as strategic partnerships, acquisitions, and leadership changes.

Beyond the business aspects, our feed highlights Novo Nordisk's commitment to corporate social responsibility and sustainability. From initiatives to improve access to diabetes care in developing countries to efforts to reduce the company's environmental footprint, we provide a comprehensive view of Novo Nordisk's impact on global health and society.

As the prevalence of diabetes and obesity continues to rise worldwide, Novo Nordisk plays a crucial role in addressing these global health challenges. Our NewsNow feed on Novo Nordisk brings you the most relevant and up-to-date information from reliable sources, helping you stay informed about this innovative and influential healthcare company.

Publication filters

Notifications

Unsubscribe from Breaking News

Sorry, no headlines or news topics were found. Please try different keywords.